Massimo Fabiani

10PUBLICATIONS
29CO-AUTHORS
Major global burdens of diseaseEpidemiological modellingEpidemiological methodsAboriginal and Torres Strait Islander theory of change models for healthPolitical economy and social change
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 27, 2026
Adapted XBB.1.5 vaccine effectiveness against severe COVID-19 outcomes among immunocompromised persons in 2023-24 in six European countries: a VEBIS-EHR network study.

|Mar 16, 2025
Comparison of two methods for the estimation of COVID-19 vaccine effectiveness of the autumnal booster within the VEBIS-EHR network in 2022/23.

Susana Monge, James Humphreys, Nathalie Nicolay

|Nov 13, 2024
Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the Omicron BA.2.86/JN.1 period among older adults in seven European countries: A VEBIS-EHR network study.

Baltazar Nunes, James Humphreys, Nathalie Nicolay

|Jun 07, 2024
The impact of underreported infections on vaccine effectiveness estimates derived from retrospective cohort studies.

Chiara Sacco, Mattia Manica, Valentina Marziano

|May 18, 2022
COVID-19 vaccines coverage and effectiveness against SARS-CoV-2 infection among residents in the largest Health Authority of Lazio region (Italy): a population-based cohort study.

Valeria Fano, Enzo Coviello, Dario Consonni

|Apr 07, 2022
Effectiveness of an mRNA vaccine booster dose against SARS-CoV-2 infection and severe COVID-19 in persons aged ≥60 years and other high-risk groups during predominant circulation of the delta variant in Italy, 19 July to 12 December 2021.

Massimo Fabiani, Maria Puopolo, Antonietta Filia

Pageof 2

Frequent Collaborators

1 joint publications

Ernesto Aitella

1 joint publications

Fabio De Bartolomeis

1 joint publications

Corrado Astarita

1 joint publications

Eliana Ferroni